logo
Military Metals Announce AGM Results

Military Metals Announce AGM Results

Yahoo21-02-2025

Vancouver, British Columbia--(Newsfile Corp. - February 21, 2025) - Military Metals Corp (CSE: MILI) (OTCQB: MILIF) (FSE: QN90) (the "Company" or "MILI") is pleased to announce voting results for its annual general meeting of shareholders ("AGM") that was held on Thursday, February 20, 2025.
At the AGM, shareholders set the size of the board of directors at four and the following nominees were elected:
Scott Eldridge, Chief Executive Officer
Michael Carew, Independent Director
Mark Saxon, Independent Director
Stephen Sulis, Independent Director
Shareholders also approved:
The appointment of Smythe LLP as the auditor of the Company for the ensuing fiscal year,
Authorization for the directors to fix the remuneration paid to the auditor,
A resolution authorizing the continuation of Company's rolling stock option plan and
A resolution authorizing the continuation of the Company's incentive share unit plan.
Following the AGM, Latika Prasad, a founder and former director and officer of the Company was appointed as Vice-President, Corporate Finance of the Company. The Company is looking forward to working with Ms. Prasad in her new role. The Company wishes to thank Zoran Pudar for his contributions and service during his tenure as a Director.
Investor Relations Engagement Extended
The Company further announces the extension of its agreement related to marketing and investor relations. On January 1, 2025, the Company engaged Tafin GmbH ("Tafin") to provide investor relations services with a focus on the German stock market and the German-speaking investment community in support of the company listing on the Frankfurt Stock Exchange (the "Tafin Agreement"). Pursuant to the terms of the Tafin Agreement, Tafin provides the Company with marketing services, which includes social media management, content creation, distribution, digital marketing, including, but not limited to, the preparation of articles and coverages on multiple financial platforms and newsletters, and translation and distribution of press releases in Germany and any other marketing services as agreed upon by the Company and Tafin (the "Tafin Services"). The Tafin Agreement has been extended by a term of two (2) months commencing on March 1, 2025. The Company will make a one-time payment to Tafin of EUR 200,000 (CAD$297,720), as consideration for the provision of the Tafin Services. Marco Marquardt is and will continue to provide the Tafin Services to the Company on behalf of Tafin and may be contacted at +49 6128 9792946 or team@finanzmedien.gmbh, Rosenweg 28, 65232 Taunusstein, Germany. The Company has not and will not issue any securities to Tafin as compensation. Both Tafin and Marco Marquardt are arm's length to the Company and do not have any interest, direct or indirect, in the Company or its securities nor do they have any right to acquire such an interest.
About Military Metals Corp.
The Company is a British Columbia-based publicly listed company engaged in the acquisition, exploration and development of mineral properties with a focus on antimony.
ON BEHALF OF THE BOARD OF DIRECTORS
For more information, please contact:
Scott EldridgeCEO and Directorscott@militarymetalscorp.com and info@militarymetalscorp.comFor enquiries, please call 604-537-7556
This news release contains "forward-looking information". Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information in this news release includes statements related to the mineral resource estimation work and the provision of promotional services. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. These include meeting the conditions of the Definitive Agreements, geopolitical developments related to the supply of antimony, the continued use of antimony and availability of alternatives, availability of capital and labour in respect of the properties that are the subject of this news release, the results of any future exploration activities, which cannot be guaranteed, and such other factors as may impact both and any future activities in respect of the properties.. Additional risk factors can also be found in the Company's public filings under the Company's SEDAR+ profile at www.sedarplus.ca. Forward-looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward looking statements if circumstances, management's estimates or opinions should change, except as required by securities legislation. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements.
The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/241907

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Aya Gold & Silver Closes Bought Deal Offering with Full Exercise of Over-Allotment Option for Gross Proceeds of $143.8 Million
Aya Gold & Silver Closes Bought Deal Offering with Full Exercise of Over-Allotment Option for Gross Proceeds of $143.8 Million

Hamilton Spectator

time12 minutes ago

  • Hamilton Spectator

Aya Gold & Silver Closes Bought Deal Offering with Full Exercise of Over-Allotment Option for Gross Proceeds of $143.8 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. MONTREAL, June 18, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) ('Aya' or the 'Company') is pleased to announce that it has closed its previously announced and upsized underwritten public offering of common shares in the capital of the Company (the 'Shares') at a price of $13.35 per Share, including the full exercise of the over-allotment option, for aggregate gross proceeds of approximately $143,750,000 (the 'Offering'). Desjardins Capital Markets acted as sole bookrunner, along with National Bank Financial Inc. and BMO Capital Markets as co-lead underwriters, with a syndicate of underwriters comprised of CIBC World Markets Inc., Raymond James Ltd., Stifel Nicolaus Canada Inc., Scotia Capital Inc., SCP Resource Finance LP, Beacon Securities Limited, and INFOR Financial Inc. (collectively, the 'Underwriters'). The Company intends to use the net proceeds of the Offering to advance its business objectives, including for the advancement of its exploration program at Boumadine, the exploration program at Zgounder Regional, and for working capital and general corporate purposes. 'With the closing of this financing and the full exercise of the over-allotment option, Aya is now in its strongest liquidity position to date,' said Benoit La Salle, President & CEO. 'This capital gives us the flexibility to fully unlock the value of our Boumadine project, while continuing to deliver strong operational performance at Zgounder, maximize cash flow, and deliver long-term value for all shareholders. We thank our investors for their continued confidence and support.' The Offering was completed by way of a prospectus supplement (the 'Supplement') to the short form base shelf prospectus of the Company dated June 10, 2025 (the 'Base Prospectus'), which supplement was filed on June 12, 2025. The Base Prospectus and the Supplement can be found on SEDAR+ at and contain important detailed information about the Offering. This news release shall not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of the securities in any jurisdiction where such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the '1933 Act'), and may not be offered or sold in the United States absent registration under the 1933 Act and all applicable U.S. state securities laws, or in compliance with applicable exemptions from such registration requirements. About Aya Gold & Silver Inc. Aya Gold & Silver Inc. is a rapidly growing, Canada-based silver producer with operations in the Kingdom of Morocco. The only TSX-listed pure silver mining company, Aya operates the high-grade Zgounder Silver Mine and is exploring its properties along the prospective South-Atlas Fault, several of which have hosted past-producing mines and historical resources. Aya's management team has been focused on maximising shareholder value by anchoring sustainability at the heart of its operations, governance, and financial growth plans. For additional information, please visit Aya's website at . Or contact Forward-Looking Statements Certain information in this news release related to the Company is forward-looking information and is prospective in nature. Forward-looking information is not based on historical facts, but rather on current expectations and projections about future events, and is therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking information. The information generally can be identified by the use of forward-looking words such as 'may', 'should', 'could', 'intend', 'estimate', 'plan', 'anticipate', 'expect', 'believe' or 'continue', or the negative thereof or similar variations. Forward-looking information in this news release include statements regarding the intended use and anticipated benefits of the net proceeds of the Offering. There are numerous risks and uncertainties that could cause actual results and Aya's plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; (ii) risks inherent in the mineral production and exploration sectors in general; (iii) that the net proceeds of the Offering may need to be used other than as set out in this news release, as well as other risks and uncertainties which are more fully described in Aya's 2024 Annual Information Form dated March 31, 2025, and in other filings of Aya with securities and regulatory authorities which are available on SEDAR+ at . Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward‐looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such forward‐looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward‐looking information. Such forward‐looking information has been provided for the purpose of assisting investors in understanding the Company's business, operations and exploration plans and may not be appropriate for other purposes. Accordingly, readers should not place undue reliance on forward‐looking information. Forward‐looking information is given as of the date of this press release, and the Company does not undertake to update such forward‐looking information except in accordance with applicable securities laws.

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward
Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward

Miami Herald

time27 minutes ago

  • Miami Herald

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward

President and COO Judy Murrah Appointed New Chairperson of the Board of Directors and CEO STONY BROOK, NY / ACCESS Newswire / June 17, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that Chairperson and Chief Executive Officer Dr. James A. Hayward is retiring from the Company and will step down from the Board of Directors effective June 18, 2025, following a distinguished 20-year term. During his tenure, Dr. Hayward was instrumental in transforming the Company's proprietary DNA production and detection technologies into commercial platforms, thereby establishing the foundation for Applied DNA's current market offerings. Furthermore, the Board of Directors of Applied DNA has appointed Judy Murrah to the roles of Chairperson, Board Director, and Chief Executive Officer in addition to retaining her current position as President. Ms. Murrah will lead the executive management team, which comprises Clay Shorrock, Chief Legal Officer and President of LineaRx, the Company's biotherapeutics subsidiary, and Beth Jantzen, Chief Financial Officer. With over a decade of operational leadership at Applied DNA, Ms. Murrah has been influential in driving product commercialization, business scaling, and, more recently, the launch of the Company's GMP-compliant DNA manufacturing capabilities. She was previously with Symbol Technologies ("Symbol"), where she played key roles in the company's growth from an early-stage company to an enterprise with approximately $2 billion in revenue and 5,000 employees, holding successive Vice President positions across Sales, Marketing, and Information Technology. Following Symbol's acquisition by Motorola, Inc. ("Motorola"), she held strategic leadership roles at Motorola, overseeing critical financial management, quality, and program management initiatives during significant business transformations, mergers, acquisitions, and divestitures. Ms. Murrah is an inventor on 14 U.S. patents and holds an MBA from Harvard Business School. Board Director Robert C. Catell stated, "On behalf of all the employees of the Company and the Board of Directors, I offer sincere thanks to Jim for his many years of scientific innovation, personal contribution, and passion he brought to Applied DNA. His accomplishments and impact are wide-ranging and will endure with the Applied DNA team and the local Long Island community." Continued Mr. Catell, "Judy has played an increasingly key role in recent years and has helped to grow who we are today as a company. Applied DNA is poised for opportunity with an established biotherapeutic manufacturing capability that we believe is proven to address the manufacturing challenges identified by the industry. Driving it to deployment and scale with customers, partners, and regulators is our next mission, and the Board is confident that Judy's leadership will put the Company on the best path forward to maximize long-term shareholder value." Added Ms. Murrah, "I am honored to take on the Chairperson and CEO roles and lead our associates and Applied DNA forward at this important inflection point, as we focus on our most promising aspects of our businesses, drive increased operating efficiency, and navigate the current macro environment." About Applied DNA Sciences Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in two business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; and (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services. Visit for more information. Follow us on X and LinkedIn. Forward-Looking Statements The statements made by Applied DNA in this press release may be "forward-looking" in nature within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe Applied DNA's future plans, projections, strategies, and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. These forward-looking statements are based largely on the Company's expectations and projections about future events and future trends affecting our business and are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements, including statements regarding the ability of Ms. Judy Murrah to successfully replace Dr. James Hayward as Chairperson and CEO of the Company, its goal to position the Company for long term-growth and value creation and the potential to achieve that goal and the future success of its Linea DNA and Linea IVT platforms.. Actual results could differ materially from those projected due to its history of net losses, limited financial resources, substantial doubt regarding its ability to continue as a going concern, unknown future demand for its biotherapeutics products and services, the unknown amount of revenues and profits that will result from our Linea IVT and/or Linea DNA platforms, the fact that there has never been a commercial drug product utilizing the LineaDNA and/or IVT platforms approved for therapeutic use, the ability of the Company's common stock to remain listed on Nasdaq as well as various other factors detailed from time to time in Applied DNA's SEC reports and filings, including its Annual Report on Form 10-K filed on December 17, 2024, its Quarterly Reports on Form 10-Q filed on February 13, 2025, and May 15, 2025, and other reports it files with the SEC, which are available at Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date hereof or to reflect the occurrence of unanticipated events, unless otherwise required by law. Applied DNA Sciences Contact: Investor Relations contact: Sanjay M. Hurry, 917-733-5573, Web: SOURCE: Applied DNA Sciences, Inc.

KWESST Receives Order For Prototypes Of Its Next-Generation Battlefield Laser Detection System For Major North American Armored Vehicle Program
KWESST Receives Order For Prototypes Of Its Next-Generation Battlefield Laser Detection System For Major North American Armored Vehicle Program

Yahoo

time29 minutes ago

  • Yahoo

KWESST Receives Order For Prototypes Of Its Next-Generation Battlefield Laser Detection System For Major North American Armored Vehicle Program

Ottawa, Ontario--(Newsfile Corp. - June 18, 2025) - KWESST Micro Systems Inc. (NASDAQ: KWE) (NASDAQ: KWESW) (TSXV: KWE) (FSE: 62U1) ("KWESST" or the "Company"), a leader in advanced tactical systems, today announced receipt of a first order from a defense systems integrator for prototypes of its newest generation of battlefield laser detection system ("BLDS") for a major North American armored vehicle program. On August 4, 2023, KWESST delivered earlier versions of the BLDS technology to an overseas NATO country through a European defense integrator. "The order announced today is a major validation of the strategic importance of our latest BLDS technology," said Sean Homuth, President and CEO of KWESST. "It's a leap ahead in capability, combining low-cost in a flexible form factor for deployment in either soldier-worn or vehicle mounted configurations, enabling many more sensors to be deployed and networked for real-time situational awareness and drastically improved survivability of soldiers and high-value targets on the battlefield." "The modern battlefield has changed," added Homuth. "Lasers are now a silent, invisible threat that can turn any soldier or vehicle into a target in seconds. BLDS gives them back those seconds so they have a fighting chance." BLDS was developed in response to the increase in laser-guided threats on the battlefield, such as Laser Target Designators (LTDs), Laser Range Finders (LRFs), and beam-riding munitions. In modern conflicts – most notably Ukraine – these systems have dramatically increased the lethality of conventional weapons, enabling precision targeting of personnel, vehicles and fortifications with devastating effectiveness. The non-networked BLDS prototypes on order are ready for delivery to the North American military armored vehicle program, subject to customary finalization of documentation. Once delivered, they will undergo performance testing of the lased-detection technology in a wide range of operational environments and scenarios in anticipation of the forthcoming fully-networked version. For interested customers, KWESST expects to have prototypes available of fully-networked versions, incorporating its proprietary approach to real-time detection, classification and dissemination of laser threats by fall of 2025. For further information, please contact: Sean Homuth, President and Chief Executive Officer homuth@ David Luxton, Chairmanluxton@ Jason Frame, Investor Relations +1 (587) 225-2599 frame@ About KWESST KWESST (TSXV: KWE) (TSXV: (NASDAQ: KWE) (NASDAQ: KWESW) (FSE: 62U1) develops and commercializes breakthrough next-generation tactical systems for military and security forces. The company's current portfolio of offerings includes digitization of tactical forces for real-time shared situational awareness and targeting information from any source (including drones) streamed directly to users' smart devices and weapons. Other KWESST products include countermeasures against threats such as electronic detection, lasers and drones. These systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems, and all come integrated with TAK. The company also has a new proprietary non-lethal product line branded PARA OPSTM with applications across all segments of the non-lethal market, including law enforcement. The Company is headquartered in Ottawa, Canada, with representative offices in London, UK and Abu Dhabi, UAE. For more information, please visit Forward-Looking Statements This press release contains "forward-looking statements" and "forward-looking information" within the meaning of Canadian and United States securities laws (collectively, "forward-looking statements"), which may be identified by the use of terms and phrases such as "may", "would", "should", "could", "expect", "intend", "estimate", "anticipate", "plan", "foresee", "believe", or "continue", the negative of these terms and similar terminology, including references to assumptions, although not all forward-looking statements contain these terms and phrases. Forward-looking statements are provided for the purposes of assisting the reader in understanding us, our business, operations, prospects and risks at a point in time in the context of historical and possible future developments and therefore the reader is cautioned that such information may not be appropriate for other purposes. Such forward-looking statements are based on the current expectations of KWESST's management and are based on assumptions and subject to risks and uncertainties. Although KWESST's management believes that the assumptions underlying such forward-looking statements are reasonable, they may prove to be incorrect. The forward-looking statements discussed in this press release may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting KWESST, including KWESST's inability to secure contracts and subcontracts (on the timelines, size and scale expected or at all) including completion of the delivery of BLDS prototype units to the customer, statements of work and orders for its products in 2025 and onwards for reasons beyond its control, the renewal or extension of agreements beyond their original term, the granting of patents applied for by KWESST, inability to finance the scale up to full commercial production levels for its physical products, growth in expected demand for products, successful launch of new products, achieving supply chain efficiency, impact on local economy and job creation, reducing trade barrier or tariffs, inability to secure key partnership agreements to facilitate the contract manufacturing, outsourcing and logistics for its PARA OPSTM products, overall interest in KWESST's products being lower than anticipated or expected; general economic and stock market conditions; adverse industry events; future legislative and regulatory developments in Canada, the United States and elsewhere; the inability of KWESST to implement and execute its business strategies; risks and uncertainties detailed from time to time in KWESST's filings with the Canadian Security Administrators and the United States Securities and Exchange Commission, and many other factors beyond the control of KWESST. Although KWESST has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and KWESST undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Neither the TSX Venture Exchange nor its respective Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store